Mixing brands of COVID-19 vaccines offers strong protection against virus, study suggests

Mixing brands of COVID-19 vaccines can create strong protection against COVID-19, early results of a British study suggest, The New York Times reported June 28.

In a clinical trial that began in February, volunteers showed high levels of antibodies and immune cells after getting one dose of Pfizer's COVID-19 vaccine and one dose of AstraZeneca's.